<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 28 Jul 2025 13:32:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>EMA Recommends Romvimza for Tenosynovial Giant Cell Tumor</title><link>https://www.medscape.com/viewarticle/ema-recommends-romvimza-tenosynovial-giant-cell-tumor-2025a1000jw3?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint deterioration. Medscape Medical N...</description><pubDate>Mon, 28 Jul 2025 17:11:33 GMT</pubDate></item><item><title>Weight Loss Drug Demand Risks Overwhelming Pharmacies</title><link>https://www.medscape.com/viewarticle/weight-loss-drug-demand-risks-overwhelming-pharmacies-2025a1000jvu?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>A surge in demand for weight loss medication is overwhelming pharmacies, prompting calls for tighter regulation and clearer NHS guidance. Medscape New...</description><pubDate>Mon, 28 Jul 2025 16:33:25 GMT</pubDate></item><item><title>EMA Backs First Oral Treatment for Hereditary Angioedema</title><link>https://www.medscape.com/viewarticle/ema-backs-first-oral-treatment-hereditary-angioedema-2025a1000jvq?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>A key advantage of the drug is its oral route of administration, offering patients a more convenient alternative to injectable therapies. Medscape Med...</description><pubDate>Mon, 28 Jul 2025 16:21:59 GMT</pubDate></item><item><title>EMA Greenlights Voranigo for IDH-Mutant Grade 2 Glioma</title><link>https://www.medscape.com/viewarticle/ema-greenlights-voranigo-idh-mutant-grade-2-glioma-2025a1000jvb?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>If approved by the European Commission, Voranigo will be the first targeted therapy for grade 2 isocitrate dehydrogenase-mutant glioma in the EU. Meds...</description><pubDate>Mon, 28 Jul 2025 14:29:16 GMT</pubDate></item><item><title>Investigate Shortness of Breath: Here’s How</title><link>https://www.medscape.com/viewarticle/investigate-shortness-breath-heres-how-2025a1000jv2?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Primary care physicians are often the first stop for patients with symptoms of shortness of breath. Here’s what to look for. Medscape Medical News</description><pubDate>Mon, 28 Jul 2025 14:27:55 GMT</pubDate></item></channel></rss>